Please read our Data Protection & Use Notification to learn more.
Arcadia University welcomes all Knights for the Fall 2021 semester. We look forward to campus coming to life with classes, activities, and events as we remain diligent in our COVID mitigation efforts.
The University is proud to announce that it is the recipient of a U.S. Department of Education Title III Strengthening Institutions Program Grant for the amount of $2.25 million over five years for work designed to increase student achievement, persistence, and retention.
1,853 Minutes of Giving
6 a.m. on Tuesday, Nov. 30 through 12:53 p.m. on Wednesday, Dec. 1
Join the entire Arcadia community of alumni, faculty, staff, friends, students, and donors as we UKnight to make a difference for Arcadia and our students. With exciting giving challenges, special programming, and plenty of Arcadia spirit, we'll charge towards another record-setting year of support for Arcadia University.
Our award-winning student blog, Because Arcadia, will help you prepare for and enhance your time at Arcadia.
Message from President Ajay Nair
As many of us have come to appreciate, a fully immersed, in-person semester at Arcadia University is a gratifying educational experience. Each of us—student, faculty, staff—has a role in facilitating this experience, which can only occur with a healthy and safe University community. This is why we will not and cannot compromise on protecting our University community members.
Information on the spread of the COVID-19 Delta variant is changing rapidly. There has been an increase in the transmission of the Delta variant in our region. The neighboring City of Philadelphia has mandated vaccinations for all students, faculty, and staff at higher education institutions. In light of this increase and mandate, Arcadia has updated our interim vaccination policy and accelerated the timeline of our vaccine requirement.
Anyone unvaccinated after Oct. 1 is required to continue with weekly surveillance testing. Those who have not been granted an exemption from the Interim COVID-19 Vaccination Policy, or who do not participate in surveillance testing or other mitigation measures where required, may face the possibility of restricted access and potentially disciplinary action.